BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)

BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX), a specialty pharmaceutical company, is committed to developing products for female sexual health, menopause, contraception and male hypogonadism. Lead products within their produce line include LibiGel® (transdermal testosterone gel), which is in Phase III clinical development under a U.S. Food and Drug Administration (FDA) SPA (Special Protocol Assessment); and Elestrin™ (estradiol gel) which has been developed through FDA approval. For further information, visit the Company’s web site at www.biosantepharma.com.